Cryoablation for Monomorphic Ventricular Tachycardia (VTS) | MicrobiomeTrials← Back to trialsNCT07650032
Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2027-03-31
Enrollment target: 100 participants Locations- Banner University Medical Center Phoenix, Phoenix, Arizona, United States
- MemorialCare Long Beach Medical Center, Long Beach, California, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Northwell Health- Staten Island University Hospital, Staten Island, New York, United States
- Hospital of University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Medical Center of South Carolina (MUSC), Charleston, South Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- McGill University Health Centre (MUHC), Montreal General Hospital (MGH), Montreal, Quebec, Canada
- Montreal Hear Institute, Montreal, Canada
Other microbiome trials you might be interested in
Sustained Monomorphic VT (MMVT)Recurrent Ventricular Tachycardia
This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guide…
Phoenix, United StatesEst. completion Apr 30, 2028
Ventricular Arrhythmias
This is a prospective, single-center, single-arm exploratory clinical study designed to evaluate the efficacy and safety…
Multiple LocationsEst. completion Dec 2027
ENROLLING_BY_INVITATION
Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy
Ventricular tachycardia (VT, a potentially fatal condition where the ventricle of the heart beats rapidly) superimposed …
Phoenix, United StatesCompleted Oct 2026